References used to create this graphic: Kakoullis, Loukas, Stylianos Louppides, Eleni Papachristodoulou, and George Panos. “Porphyrias and Photosensitivity: Pathophysiology for the Clinician.” ...

These cause the attacks of physical pain in Sue's form of the disease. In other porphyrias the proteins can cause skin problems. There is some speculation King George III had porphyria.

As previously reported, Raymond James analyst Danielle Brill upgraded Disc Medicine (IRON) to Strong Buy from Outperform with a price target of ...

Jefferies initiated its coverage of hematology-focused biotech Disc Medicine (NASDAQ:IRON) with a buy recommendation on Wednesday, citing the potential of its lead candidate, bitopertin, targeted at a ...

Count Dracula might have been an invention of the author Bram Stoker, but there is a real-life disease called acute intermittent porphyria that somewhat mimics the symptoms of horror’s scariest ...

31 Absolute contraindications to medical management with misoprostol and mifepristone include an intrauterine device in situ, if it cannot be removed; anti-coagulant use, other than acetylsalicylic ...

Since Carl Djerassi and Gregory Pincus brought the proof of concept of OCs in the early 1960s, with a pill containing norethidronel as a progestin and mestranol as an estrogen, many different ...

Disc is planning to develop bitopertin as a potential treatment for a range of hematologic diseases including erythropoietic ...

Third-generation oral contraceptives are an association of low-dose ethinyl estradiol and potent testosterone-derived progestins, developed in order to improve general and vascular tolerance. They ...

CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta ...

which are in late stage development for acute hepatic porphyrias and hypercholesteroaemia respectively. He said: “With the potential for the sequential launches of several new medicines in the ...

CASGEVY approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) in Switzerland and Canada- -45 authorized treat ...